Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).

NCT ID: NCT05562336

Last Updated: 2022-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-31

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare choroidal neo-vascular membrane criteria in cases of age-related macular degeneration and cases of pathological myopia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients will be examined by optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-angio) .

The size, the location, the criteria of the choriodal neovascular membrane will be examined and imaged.

Study include 50 cases of CNV in age related macular degeneration and 50 cases of CNV in pathological myopia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with age related macular degeneration with CNV

Optical coherence tomography angiography

Intervention Type DEVICE

Optical coherence tomography (OCT) is a noninvasive imaging method that uses reflected light to create pictures of the back of your eye

Patients with pathological myopia with CNV

Optical coherence tomography angiography

Intervention Type DEVICE

Optical coherence tomography (OCT) is a noninvasive imaging method that uses reflected light to create pictures of the back of your eye

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Optical coherence tomography angiography

Optical coherence tomography (OCT) is a noninvasive imaging method that uses reflected light to create pictures of the back of your eye

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with age related macular degeneration should be at least 50 years of age with CNV with no other causes.

Patients with pathological myopia where axial length more than 26 mm or refractive power more than -6 diopter with CNV in OCT with clear media and OCT-angio can be used.

Exclusion Criteria

* Exclude other pathological causes of CNV .
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arwa Mostafa Ahmed

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arwa El-shabrakhity

Role: CONTACT

Phone: 0111 462 4205

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology. 1996 Aug;103(8):1260-70. doi: 10.1016/s0161-6420(96)30512-5.

Reference Type BACKGROUND
PMID: 8764797 (View on PubMed)

Secretan M, Kuhn D, Soubrane G, Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol. 1997 Oct-Dec;7(4):307-16. doi: 10.1177/112067219700700401.

Reference Type BACKGROUND
PMID: 9457451 (View on PubMed)

Miller DG, Singerman LJ. Vision loss in younger patients: a review of choroidal neovascularization. Optom Vis Sci. 2006 May;83(5):316-25. doi: 10.1097/01.opx.0000216019.88256.eb.

Reference Type BACKGROUND
PMID: 16699445 (View on PubMed)

Kovach JL, Schwartz SG, Flynn HW Jr, Scott IU. Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol. 2012;2012:786870. doi: 10.1155/2012/786870. Epub 2012 Feb 28.

Reference Type BACKGROUND
PMID: 22523653 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-22-09-03

Identifier Type: -

Identifier Source: org_study_id